Skip to main content
. 2021 May 31;10(12):e019588. doi: 10.1161/JAHA.120.019588

Figure 1. Utilization of surgical aortic valve replacement (SAVR) and transcatheter aortic valve replacement (TAVR) across United States Food and Drug Administration (FDA) approval timeline.

Figure 1